Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37951 - 37975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	NFE2L3	9603	upregulated	entinostat results in increased expression of NFE2L3 mRNA	7p15.2	A21035
Entinostat	Investigational	NFIB	4781	upregulated	entinostat results in increased expression of NFIB mRNA	9p23-p22.3	A21037
Entinostat	Investigational	NFIC	4782	upregulated	entinostat results in increased expression of NFIC mRNA	19p13.3	A21035
Entinostat	Investigational	NFRKB	4798	downregulated	entinostat results in decreased expression of NFRKB mRNA	11q24.3	A21037
Entinostat	Investigational	NGEF	25791	upregulated	entinostat results in increased expression of NGEF mRNA	2q37.1	A21037 A21035
Entinostat	Investigational	NHLH2	4808	upregulated	entinostat results in increased expression of NHLH2 mRNA	1p13.1	A21037
Entinostat	Investigational	NID1	4811	upregulated	entinostat results in increased expression of NID1 mRNA	1q42.3	A21035
Entinostat	Investigational	NIFK-AS1	254128	downregulated	entinostat results in decreased expression of NIFK-AS1 mRNA	2q14.3	A21037
Entinostat	Investigational	NIN	51199	downregulated	entinostat results in decreased expression of NIN mRNA	14q22.1	A21037 A21035
Entinostat	Investigational	NIPAL3	57185	upregulated	entinostat results in increased expression of NIPAL3 mRNA	1p36.11	A21035
Entinostat	Investigational	NKD2	85409	upregulated	entinostat results in increased expression of NKD2 mRNA	5p15.33	A21035
Entinostat	Investigational	NKX2-3	159296	downregulated	entinostat results in decreased expression of NKX2-3 mRNA	10q24.2	A21035
Entinostat	Investigational	NLGN1	22871	downregulated	entinostat results in decreased expression of NLGN1 mRNA	3q26.31	A21037
Entinostat	Investigational	NLGN2	57555	upregulated	entinostat results in increased expression of NLGN2 mRNA	17p13.1	A21035
Entinostat	Investigational	NLN	57486	upregulated	entinostat results in increased expression of NLN mRNA	5q12.3	A21037
Entinostat	Investigational	NME8	51314	upregulated	entinostat results in increased expression of NME8 mRNA	7p14.1	A21035
Entinostat	Investigational	NMI	9111	upregulated	entinostat results in increased expression of NMI mRNA	2q23.3	A21037
Entinostat	Investigational	NMNAT3	349565	upregulated	entinostat results in increased expression of NMNAT3 mRNA	3q23	A21035
Entinostat	Investigational	NMRK1	54981	upregulated	entinostat results in increased expression of NMRK1 mRNA	9q21.13	A21037 A21035
Entinostat	Investigational	NMRK2	27231	upregulated	entinostat results in increased expression of NMRK2 mRNA	19p13.3	A21037
Entinostat	Investigational	NMU	10874	upregulated	entinostat results in increased expression of NMU mRNA	4q12	A21035
Entinostat	Investigational	NNMT	4837	upregulated	entinostat results in increased expression of NNMT mRNA	11q23.1	A21035
Entinostat	Investigational	NOCT	25819	upregulated	entinostat results in increased expression of NOCT mRNA	4q31.1	A21037
Entinostat	Investigational	NOD2	64127	upregulated	entinostat results in increased expression of NOD2 mRNA	16q12.1	A21035
Entinostat	Investigational	NOG	9241	downregulated	entinostat results in decreased expression of NOG mRNA	17q22	A21037

Displaying entries 37951 - 37975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability